(Q58811082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Giuseppe Cabibbo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Giuseppe Cabibbo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Fabio Piscaglia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Antonio Grieco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Erica Villa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

5

Claudio Zavaglia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Calogero Cammà

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Massimo Colombo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

SOFIA (SOraFenib Italian Assessment) study group

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

2055-2063

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

12 February 2020

cites work

1 reference

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

21 January 2018

1 reference

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis

21 January 2018

1 reference

Pragmatic trials--guides to better patient care?

21 January 2018

1 reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

21 January 2018

1 reference

The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria

21 January 2018

1 reference

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

21 January 2018

1 reference

Estrogen Receptor Classification for Hepatocellular Carcinoma: Comparison With Clinical Staging Systems

21 January 2018

1 reference

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

21 January 2018

1 reference

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib

21 January 2018

1 reference

Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

21 January 2018

1 reference

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

21 January 2018

1 reference

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

The value of observational research in liver diseases

1 reference

7 January 2021

Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?

1 reference

7 January 2021

Sorafenib therapy in patients with advanced hepatocellular carcinoma in advanced liver cirrhosis

1 reference

7 January 2021

Pharmacology and Drug Development

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24644

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898496%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference